Oncogenic fusions of kinase genes can result in similar dysregulation such as in the case of the BCR-Abl fusion in chronic myeloid leukemia (CML), which disrupts autoinhibition through regulatory domain truncations, inducing constitutive kinase activity [14]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.